Gyuru-lanc tautomeria alkalmazasa prodrug szerek fejlesztesere

Translated title of the contribution: Application of ring-chain tautomerism for the development of prodrugs

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Many unfavourable pharmacological and physicochemical properties of drugs can be improved by the application of prodrugs. Ring-chain tautomeric prodrugs include 1,3-X,N-heterocycles prepared from difunctional compounds with aldehydes or ketones. From the ring-chain equilibria of these derivatives, the open form undergoes continuous hydrolysis to give the bioactive molecule, which can be either the original difunctional compound or an oxo compound. This concept was applied in cases of oxazolidine and thiazolidine prodrugs derived from (-)ephedrine, L-cysteine and hydrocortisone. From studies on 2-aryl-1,3-X,N-heterocycles, it has been unequivocally concluded that ring-chain tautomerism is characteristic not only for 1,3-O,N-heterocycles, but also for their 1,3-S,N- and 1,3-N,N- analogues. The ratios of the tautomeric forms involved in the equilibria of these systems are strongly influenced by the steric and electronic characters of the substituents. The results demonstrate that the transformation of a drug candidate to a ring-chain tautomeric prodrug is always worthy of consideration, when the pharmacologically active compound contains a 1,2- or 1,3-amino alcohol, a diamine or an amino thiol moiety or an oxo group.

Original languageHungarian
Pages (from-to)202-207
Number of pages6
JournalActa Pharmaceutica Hungarica
Volume69
Issue number4
Publication statusPublished - Sep 1999

Fingerprint

Prodrugs
Thiazolidines
Amino Alcohols
Ephedrine
Diamines
Ketones
Sulfhydryl Compounds
Aldehydes
Pharmaceutical Preparations
Cysteine
Hydrocortisone
Hydrolysis
Pharmacology

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Gyuru-lanc tautomeria alkalmazasa prodrug szerek fejlesztesere. / Lázár, L.; Fülöp, F.

In: Acta Pharmaceutica Hungarica, Vol. 69, No. 4, 09.1999, p. 202-207.

Research output: Contribution to journalArticle

@article{7d9017f0a8ba4e94a361b2ba079b3a18,
title = "Gyuru-lanc tautomeria alkalmazasa prodrug szerek fejlesztesere",
abstract = "Many unfavourable pharmacological and physicochemical properties of drugs can be improved by the application of prodrugs. Ring-chain tautomeric prodrugs include 1,3-X,N-heterocycles prepared from difunctional compounds with aldehydes or ketones. From the ring-chain equilibria of these derivatives, the open form undergoes continuous hydrolysis to give the bioactive molecule, which can be either the original difunctional compound or an oxo compound. This concept was applied in cases of oxazolidine and thiazolidine prodrugs derived from (-)ephedrine, L-cysteine and hydrocortisone. From studies on 2-aryl-1,3-X,N-heterocycles, it has been unequivocally concluded that ring-chain tautomerism is characteristic not only for 1,3-O,N-heterocycles, but also for their 1,3-S,N- and 1,3-N,N- analogues. The ratios of the tautomeric forms involved in the equilibria of these systems are strongly influenced by the steric and electronic characters of the substituents. The results demonstrate that the transformation of a drug candidate to a ring-chain tautomeric prodrug is always worthy of consideration, when the pharmacologically active compound contains a 1,2- or 1,3-amino alcohol, a diamine or an amino thiol moiety or an oxo group.",
author = "L. L{\'a}z{\'a}r and F. F{\"u}l{\"o}p",
year = "1999",
month = "9",
language = "Hungarian",
volume = "69",
pages = "202--207",
journal = "Acta Pharmaceutica Hungarica",
issn = "0001-6659",
publisher = "Magyar Gyogyszereszeti Tarsasag",
number = "4",

}

TY - JOUR

T1 - Gyuru-lanc tautomeria alkalmazasa prodrug szerek fejlesztesere

AU - Lázár, L.

AU - Fülöp, F.

PY - 1999/9

Y1 - 1999/9

N2 - Many unfavourable pharmacological and physicochemical properties of drugs can be improved by the application of prodrugs. Ring-chain tautomeric prodrugs include 1,3-X,N-heterocycles prepared from difunctional compounds with aldehydes or ketones. From the ring-chain equilibria of these derivatives, the open form undergoes continuous hydrolysis to give the bioactive molecule, which can be either the original difunctional compound or an oxo compound. This concept was applied in cases of oxazolidine and thiazolidine prodrugs derived from (-)ephedrine, L-cysteine and hydrocortisone. From studies on 2-aryl-1,3-X,N-heterocycles, it has been unequivocally concluded that ring-chain tautomerism is characteristic not only for 1,3-O,N-heterocycles, but also for their 1,3-S,N- and 1,3-N,N- analogues. The ratios of the tautomeric forms involved in the equilibria of these systems are strongly influenced by the steric and electronic characters of the substituents. The results demonstrate that the transformation of a drug candidate to a ring-chain tautomeric prodrug is always worthy of consideration, when the pharmacologically active compound contains a 1,2- or 1,3-amino alcohol, a diamine or an amino thiol moiety or an oxo group.

AB - Many unfavourable pharmacological and physicochemical properties of drugs can be improved by the application of prodrugs. Ring-chain tautomeric prodrugs include 1,3-X,N-heterocycles prepared from difunctional compounds with aldehydes or ketones. From the ring-chain equilibria of these derivatives, the open form undergoes continuous hydrolysis to give the bioactive molecule, which can be either the original difunctional compound or an oxo compound. This concept was applied in cases of oxazolidine and thiazolidine prodrugs derived from (-)ephedrine, L-cysteine and hydrocortisone. From studies on 2-aryl-1,3-X,N-heterocycles, it has been unequivocally concluded that ring-chain tautomerism is characteristic not only for 1,3-O,N-heterocycles, but also for their 1,3-S,N- and 1,3-N,N- analogues. The ratios of the tautomeric forms involved in the equilibria of these systems are strongly influenced by the steric and electronic characters of the substituents. The results demonstrate that the transformation of a drug candidate to a ring-chain tautomeric prodrug is always worthy of consideration, when the pharmacologically active compound contains a 1,2- or 1,3-amino alcohol, a diamine or an amino thiol moiety or an oxo group.

UR - http://www.scopus.com/inward/record.url?scp=0033192159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033192159&partnerID=8YFLogxK

M3 - Article

C2 - 10544520

AN - SCOPUS:0033192159

VL - 69

SP - 202

EP - 207

JO - Acta Pharmaceutica Hungarica

JF - Acta Pharmaceutica Hungarica

SN - 0001-6659

IS - 4

ER -